182 related articles for article (PubMed ID: 17296567)
21. Long-Term Remissions of Patients With Follicular Lymphoma Grade 3 Treated With R-CHOP.
Strati P; Fowler N; Pina-Oviedo S; Medeiros LJ; Overman MJ; Romaguera JE; Nastoupil L; Wang M; Hagemeister FB; Rodriguez A; Oki Y; Westin J; Turturro F; Neelapu SS; Fayad L
Clin Lymphoma Myeloma Leuk; 2018 Jan; 18(1):e103-e108. PubMed ID: 29196178
[TBL] [Abstract][Full Text] [Related]
22. [Follicular lymphoma. High-dose immunochemotherapy with autologous blood stem cell transplantation: Results of the first prospective study in Russia].
Nesterova ES; Kravchenko SK; Mangasarova YK; Baryakh EA; Misyurina AE; Vorobyev VI; Plastinina LV; Chernova NG; Kovrigina AM; Obukhova TN; Klyasova GA; Shevelev AA; Kostina IE; Gemdzhian EG; Gaponova TV; Vorobyev AI
Ter Arkh; 2016; 88(7):62-71. PubMed ID: 27459617
[TBL] [Abstract][Full Text] [Related]
23. The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma.
Giné E; Montoto S; Bosch F; Arenillas L; Mercadal S; Villamor N; Martínez A; Colomo L; Campo E; Montserrat E; López-Guillermo A
Ann Oncol; 2006 Oct; 17(10):1539-45. PubMed ID: 16940035
[TBL] [Abstract][Full Text] [Related]
24. Divergent immunohistochemical expression of CD21 and CD23 by follicular dendritic cells with increasing grade of follicular lymphoma.
Kurshumliu F; Sadiku-Zehri F; Qerimi A; Vela Z; Jashari F; Bytyci S; Rashiti V; Sadiku S
World J Surg Oncol; 2019 Jul; 17(1):115. PubMed ID: 31269981
[TBL] [Abstract][Full Text] [Related]
25. Soluble interleukin-2 receptor level predicts survival in patients with follicular lymphoma treated with cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy in the rituximab era.
Procházka V; Papajík T; Faber E; Raida L; Kapitáňová Z; Langová K; Prouzová Z; Jarošová M; Indrák K
Leuk Lymphoma; 2014 Jul; 55(7):1584-90. PubMed ID: 24180329
[TBL] [Abstract][Full Text] [Related]
26. Treatment outcomes and clinical relevance of the Follicular Lymphoma International Prognostic Index in Korean follicular lymphoma patients treated with chemotherapy.
Maeng CH; Ahn SW; Ryu SY; Han S; Ko YH; Ji JH; Kim WS; Kim SJ
Korean J Intern Med; 2016 May; 31(3):560-9. PubMed ID: 26898595
[TBL] [Abstract][Full Text] [Related]
27. [Prognostic Significance of Follicular Lymphoma International Prognostic Index 2 (FLIPI2) in Follicular Lymphoma Patients Treated with Rituximab Maintenance].
Xu PP; Qian Y; Chen QS; Li LQ; Zhang L; Zhao WL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):426-430. PubMed ID: 28446287
[TBL] [Abstract][Full Text] [Related]
28. Absolute monocyte count in follicular lymphoma patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
Watanabe R; Tomita N; Kishimoto K; Koyama S; Ogusa E; Ishii Y; Miyashita K; Matsuura S; Fujisawa S; Hattori Y; Takasaki H; Fujita A; Ohshima R; Kuwabara H; Hashimoto C; Fujimaki K; Sakai R; Ishigatsubo Y
Leuk Res; 2013 Oct; 37(10):1208-12. PubMed ID: 23927994
[TBL] [Abstract][Full Text] [Related]
29. [Composite lymphoma consisting of Hodgkin lymphoma and follicular lymphoma].
Uchida T; Sugimoto K; Koike M
Rinsho Ketsueki; 2009 Feb; 50(2):83-6. PubMed ID: 19265299
[TBL] [Abstract][Full Text] [Related]
30. A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone.
Taskinen M; Karjalainen-Lindsberg ML; Nyman H; Eerola LM; Leppä S
Clin Cancer Res; 2007 Oct; 13(19):5784-9. PubMed ID: 17908969
[TBL] [Abstract][Full Text] [Related]
31. Prediction of high risk for death in patients with follicular lymphoma receiving rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in first-line chemotherapy.
Murakami S; Kato H; Higuchi Y; Yamamoto K; Yamamoto H; Saito T; Taji H; Yatabe Y; Nakamura S; Kinoshita T
Ann Hematol; 2016 Aug; 95(8):1259-69. PubMed ID: 27220639
[TBL] [Abstract][Full Text] [Related]
32. [Leukemization of follicular lymphoma: The features of diagnostic and clinical course of a rare form of the disease].
Nesterova ES; Kravchenko SK; Mangasarova YK; Plastinina LV; Dvirnyk VN; Kovrigina AM; Shchupletsova IA; Obukhova TN; Gemdzhian EG; Vorobyev IA; Vorobyev AI
Ter Arkh; 2017; 89(7):45-50. PubMed ID: 28766540
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of the soluble interleukin-2 receptor level after patients with follicular lymphoma achieve a response to R-CHOP.
Umino K; Fujiwara SI; Ikeda T; Toda Y; Ito S; Mashima K; Minakata D; Nakano H; Yamasaki R; Kawasaki Y; Sugimoto M; Yamamoto C; Ashizawa M; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Kanda Y
Hematology; 2017 Oct; 22(9):521-526. PubMed ID: 28413914
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of p53 and matrix metalloproteinase-9 expression in follicular lymphoma.
Pennanen H; Kuittinen O; Soini Y; Turpeenniemi-Hujanen T
Eur J Haematol; 2008 Oct; 81(4):289-97. PubMed ID: 18616513
[TBL] [Abstract][Full Text] [Related]
35. Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols.
de Jong D; Koster A; Hagenbeek A; Raemaekers J; Veldhuizen D; Heisterkamp S; de Boer JP; van Glabbeke M
Haematologica; 2009 Jan; 94(1):70-7. PubMed ID: 19059937
[TBL] [Abstract][Full Text] [Related]
36. New treatment options have changed the survival of patients with follicular lymphoma.
Fisher RI; LeBlanc M; Press OW; Maloney DG; Unger JM; Miller TP
J Clin Oncol; 2005 Nov; 23(33):8447-52. PubMed ID: 16230674
[TBL] [Abstract][Full Text] [Related]
37. Indolent Lymphomas That Present With Clinically Aggressive Features: A Subset of Low-Grade Lymphomas With a Behavior Inconsistent With the Histologic Diagnosis.
Cabanillas F; Rivera N; Pardo WI
Clin Lymphoma Myeloma Leuk; 2016 Oct; 16(10):550-557. PubMed ID: 27618361
[TBL] [Abstract][Full Text] [Related]
38. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
Seymour JF; Pro B; Fuller LM; Manning JT; Hagemeister FB; Romaguera J; Rodriguez MA; Ha CS; Smith TL; Ayala A; Hess M; Cox JD; Cabanillas F; McLaughlin P
J Clin Oncol; 2003 Jun; 21(11):2115-22. PubMed ID: 12775737
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic utility and prognostic significance of the Ki-67 labeling index in diffuse large B-cell lymphoma transformed from follicular lymphoma: a study of 76 patients.
Maeshima AM; Taniguchi H; Hori Y; Ida H; Hosoba R; Makita S; Fukuhara S; Munakata W; Suzuki T; Maruyama D; Izutsu K
Pathol Int; 2021 Oct; 71(10):674-681. PubMed ID: 34339560
[TBL] [Abstract][Full Text] [Related]
40. Follicular lymphoma: 2012 update on diagnosis and management.
Freedman A
Am J Hematol; 2012 Oct; 87(10):988-95. PubMed ID: 23001911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
